4.6 Review

Recent Advance in Aminopeptidase N (APN/CD13) Inhibitor Research

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 18, Issue 32, Pages 5011-5021

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986711797535155

Keywords

Aminopeptidase N; rational drug design; inhibitors; peptidomimetics; anti-tumor; structure activity relationship

Funding

  1. national high technology research and development program of china (863 project) [2007AA02Z314, 2009ZX09103-118]
  2. National Nature Science Foundation of China [90713041, 30772654]

Ask authors/readers for more resources

APN is an important zinc dependent metallo-exopeptidase, which can degrade the extracellular matrix, and plays an important role in tumor invasion, metastasis and angiogenesis. it has been considered as a suitable target for anti-cancer drug design. Recently, research of structure-based APN inhibitors is becoming an interesting field, and many APN inhibitors have been reported. Here we review a series of APN inhibitors and the recent progress in this field.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available